Daiwa initiated coverage of Emerson (EMR) with an Outperform rating and $147 price target The firm cites the company’s “favorable” process end market exposure, a potential discrete end market rebound, AspenTech integration and the stock’s valuation discount to peers for the Outperform rating. It sees Emerson’s increasing access to artificial intelligence models driving penetration of industrial optimization software through “seamless integration” with process control software.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- M&A News: Emerson (EMR) Eyes Full Control of AspenTech with $7.2B Deal
- China’s DeepSeek sinks tech, AT&T reports Q4 beat: Morning Buzz
- Emerson to acquire remainder of Aspen Technology for $265 per share in cash
- Trump Trade: President blasts EU regulators for targeting U.S. tech companies
- Emerson price target lowered to $135 from $137 at JPMorgan